You are here: Industry Insights > Growth

News List

Merck Q3 results: 5% revenue growth primarily driven by oncology pharmaceutical-technology
October 29, 2018
Revenue growth primarily driven by oncology.
Kilitch Drugs (India) registers a robust growth in Q1FY19 financialexpress
August 17, 2018
Net sales up four-folds (YoY) to INR 27.97 crore and registers a net profit of INR 4.17 crore
Pharma market grows by 12.7 per cent in July 2018 financialexpress
August 16, 2018
In July, growth due to price was a positive contributor, unlike previous months, when price growth was a negative factor
Lilly's cancer business loses its chief just as it's leaning on oncology for growth fiercepharma
May 28, 2018
Eli Lilly is leaning on oncology as a key pillar for growth going forward, but with news that its president of the business, Sue Mahony, Ph.D., is retiring, the drugmaker will need to find new leadership for the unit.
Eppendorf continues to generate above average growth biospectrumasia
April 27, 2018
Group sales of €690.3 million with organic growth of 7.9 per cent in local currencies.
Sanofi Pasteur posts 8.3% growth despite 2017 vaccine setbacks fiercepharma
February 12, 2018
Despite lots of challenges that cropped up during 2017, Sanofi's vaccines outfit grew revenues 8.3% in the year to €5.1 billion ($6.25 billion), helping the drug giant as its pharma segment struggled.
GSK reported 3 percent hike in 2017 sales pharmatimes
February 09, 2018
GSK has reported a sales rise of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.
Pharma market posts 7.5% growth in June financialexpress
July 14, 2017
Steady growth in run up to GST roll out
New report states growth in Pharmacy Management System market pharmaasia
May 31, 2017
Pharmacy Management System market is growing at a CAGR of 10.93% during 2017 to 2021 says a new report.
Alexion forecasts Soliris growth for 2017 in wake of probe into sales practices firstwordpharma
February 17, 2017
Alexion Pharmaceuticals on Thursday said that it anticipates Soliris sales in 2017 in the range of $3.03 billion to $3.1 billion, in line with analyst estimates. The therapy amassed about $2.8 billion in revenue for last year, compared to $2.6 billion in

Previous page 1 2 Next page